This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Sepsis Diagnostics Market

Market Insights on Sepsis Diagnostics covering sales outlook, demand forecast & up-to-date key trends

Sepsis Diagnostics Market Analysis by Product (Blood Culture Media, Assays & Reagents, Instruments, and Software), Technology (Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers), Method (Automated Diagnostics and Conventional Diagnostics), Pathogen (Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others), Test Type, End User, & Region - Forecast to 2022 - 2032

Sepsis Diagnostics Market Outlook

[341 Pages Report] During the assessment period, the worldwide sepsis diagnostics market growth is predicted to rise at a robust CAGR of 9%, from US$ 500 Mn in 2021 to US$ 1.3 Bn by 2032.

“The COVID-19 epidemic boosted sales of sepsis diagnostics devices market to become more popular as the global spread of covid-19 and sepsis cases among covid-19 patients call for quick diagnosis.”

Hospital-acquired infections (HAIs), commonly referred to as nosocomial infections, are a significant source of morbidity and death globally. Urinary tract infections, pneumonia, and sepsis are the most frequently acquired hospital-acquired illnesses (HAIs).

HAIs can result in sepsis in immunocompromised people, the elderly, and those with chronic conditions. Uses of sepsis diagnostics devices are increasing at an annual rate of 8.7% in hospitalised patients in the United States.

Annually, the CDC estimates that more than 1,000,000 cases of sepsis occur among hospitalised patients in the United States (Source: CDC, 2018). With the increasing growth of HAIs globally, demand for sepsis diagnostics devices is projected to expand in the future years.

Attributes

Details

Sepsis Diagnostics Market CAGR (2022 – 2032)

9%

Sepsis Diagnostics Market

US$ 500 Mn

Sepsis Diagnostics Market Attraction

Availability of sophisticated tech to make North America a key market

Customize this Report

Let us know your requirement to get
100% FREE customization

What is the COVID-19 Impact on Sepsis Diagnostics Market?

The sepsis diagnostic market grew impressively with a CAGR of 7.7% by the analysis in 2015. But in 2020, coronavirus infection became widespread, turning into a pandemic and impacting every commercial activity.

All the healthcare and other facilities resources were diverted to control the menace of the pandemic. In such a situation, every other non-emergency healthcare or medical facility was affected to some extent.

But contrary to any other diagnostic services, the sepsis diagnostic market experienced an uncommon boost after it was discovered that multichannel injuries, a symptom of a type of sepsis, development chances were 2% to 5% among Covid-19 patients. The market is now predicted to grow at a CAGR of 9% in the years following the pandemic.

Which Factors Contribute to the Growth of the Sepsis Diagnostics Market?

"The global sepsis diagnostics market is expected to grow due to increased R&D effort. Using a microelectrode biosensor, the sepsis diagnostic devices identify interleukin-6, a protein biomarker, in less than three minutes."

Hospital-acquired infections (HAIs), also known as nosocomial infections, are a leading source of morbidity and death around the world. Urinary tract infections, pneumonia, and sepsis are the most frequent hospital-acquired infections (HAIs). 

HAIs can cause sepsis in immunocompromised persons, the elderly, and those suffering from chronic conditions. Sepsis molecular diagnostics among hospitalised patients in the United States increases at an annual rate of 8.7%. 

It is predicted that there are more than 1,000,000 cases of sepsis molecular diagnostics among hospitalised patients in the United States each year (Source: CDC, 2018). Furthermore, with the significant growth of HAIs throughout the world, the market for sepsis diagnostic devices is projected to surge in the future years.

What are the Constraints in the Global Sepsis Diagnostics Market?

According to the National Institutes of Health, a molecular diagnostic test can cost between USD 300 and USD 3,000, which is much more expensive than blood culture tests, which can cost as little as USD 28–35. 

Although sepsis diagnostics companies are concentrating on developing automated diagnostic instruments for identifying sepsis based on sophisticated technologies such as sepsis molecular diagnostics, government hospitals (particularly in developing countries) and academic research laboratories cannot afford such systems due to funding constraints. 

Furthermore, it is becoming a significant hurdle to the market's growth for sepsis diagnostics devices.

What are the Sepsis Diagnostics Market Key Trends & Opportunities?

Sepsis is a complex condition to diagnose, and even a one-minute delay in antibiotic administration increases the risk of mortality in septic shock patients with hypertension by 7.6%. There is a greater need for early sepsis molecular diagnostics to reduce the time between the onset of sepsis and the administration of antibiotics in sepsis patients. 

There is an increase in sepsis diagnostic suppliers expanding their product offerings in point-of-care technology. Neonatal sepsis diagnostics diagnose sepsis fast and minimises overall diagnostic turnaround time. 

The BACTEC Plus, BacT/Alert, and BACTEC FX blood culturing equipment from BD Company (US) is an automated microbial detection device that may offer a fast diagnosis of sepsis in as little as three hours to the company.

How are Challenges Hindering the Growth of the Sepsis Diagnostics Market?

Sepsis is a potentially fatal illness that must be detected and treated as soon as possible by trained healthcare experts. Unfortunately, the global scarcity of competent professionals is a big problem; barely half of the patients with severe sepsis transferred by the EMS system are accompanied by a paramedic. 

The shortage of qualified paramedics has an impact on all phases of patient care, including sepsis awareness, evaluating patients for the presence of sepsis diagnostics devices, and making proper treatment decisions.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Adjacent Sepsis Diagnostics Market

Attributes

Sepsis Diagnostics Market

In-vitro Diagnostics Quality Control Market

Allergy Diagnostics Market

CAGR (2022 - 2032)

9%

5.5%

11%

Market Value(2026)

US$ 770 Mn

US$ 1.3 Bn

US$  8 Bn

Growth Factor

Rising demand for rapid diagnostic techniques to boost adoption.

Increasing adoption of third-party quality controls to drive demand.

Huge economic burden of allergic diseases and increased funding in the development of allergy diagnostics to underpin sales.

Opportunity

Availability of the latest technologies for the development of novel biomarkers to offer remunerative opportunities.

Adoption of multi-analyte controls and technological advancements to drive demand.

Emerging countries such as China and India to offer lucrative opportunities.

Key Trends

Manufacturers look at Asia Pacific market to expand their operational capacity and reduce their overhead costs.

Expansions and product releases to be the go-to- inorganic growth strategies.

Popularity of mHealth for allergy diagnosis offers affordability of diagnosis.

HAIs, also known as nosocomial infections, are a leading cause of morbidity and mortality in hospitals around the world. Urinary tract infections, pneumonia, and sepsis are the most common hospital-acquired infections (HAIs).

With the rapid rise in HAIs around the world, demand for sepsis diagnostics is expected to increase in the coming years.

Sepsis is a complex condition to diagnose, and even a one-minute delay in antibiotic administration increases the risk of death by 7.6% in septic shock patients with hypertension. As a result, there is a greater need for rapid sepsis diagnostics to reduce antibiotic therapy delays in sepsis patients. Hence, opening up a wide array of sepsis diagnostics market opportunities.

Many sepsis diagnostic companies are expanding their product offerings in point-of-care technology to detect sepsis quickly and cut down on diagnosis time. For example, an automated microbial detection system provides a three-hour, one of the crucial sepsis diagnostics companies, i.e., BD Company's (US) BACTEC Plus, BacT/Alert, and BACTEC FX blood culturing instruments turnaround time for sepsis diagnosis.

The COVID-19 pandemic had a significantly positive impact on the sales of sepsis diagnostics. The emergence of sepsis cases among covid-19 patients is likely to increase demand for rapid diagnosis, resulting in faster adoption of instruments, reagents, and assay kits for sepsis detection.

Researchers are working on a molecular diagnostic that can detect COVID-19 and sepsis while distinguishing between the two. The Hellenic Institute for the Study of Sepsis funded a study. It developed a novel optical biosensor for the early diagnosis of sepsis and severe COVID-19, with funding provided in part by Sanmina Corporation. These recent developments in the sepsis diagnostics market are expected to impact the market's growth positively.

Over the forecast period, sepsis diagnostics market growth is expected to be aided by increasing regulatory approval and introducing technologically advanced diagnostic solutions for sepsis. For example, T2 Biosystems, Inc., a California-based emerging diagnostic solutions company, received FDA-approved sepsis diagnostics for its T2Bacteria Panel, which is designed to detect specific sepsis-causing bacterial pathogens in whole human blood specimens. This is considered to scale up the sepsis diagnostics market size.

Which is the Highly Preferred Method of Sepsis Diagnostics?

Though the automated diagnostic tests are more accurate in predicting the sepsis causing pathogens, given its high price over conventional blood culture methods, it is the major challenge of its wider adoption any quickly. At the same time, the blood culture test costs around US$ 28 to US$ 30, the cost for an automated diagnostic method can be up to US$ 3000. However, increasing healthcare spending in developed and developed regions will boost the demand for automated sepsis diagnosis in the years ahead.

Another reason for predicting a positive growth for the automated molecular sepsis diagnostics market is the shortage of trained healthcare professionals capable of operating conventional sepsis diagnoses.

Which is the Key Technology Segment in the Sepsis Diagnostics Market?

Among all the technologies available for sepsis diagnostics, blood culture still dominates the market worldwide because it is extensive and less costly. Immunoassay technology is also a popular method in healthcare setups and follows blood culture in market share.

Molecular diagnostic technology has several subtypes. Polymerase Chain Reaction (PCR) test became famous in the light of the Covid-19 pandemic for detecting the novel Coronavirus infections. The other established molecular diagnostic technologies are Peptide Nucleic Acid-Fluorescent in situ hybridization, microarrays, DNA sequencing, and syndrome panel-based testing.

Which Pathogen Segment Leads in the Sepsis Diagnostic Market?

As bacterial infections are more common, the bacterial sepsis diagnostics market dominates all the other markets for different pathogen types. Therefore, sepsis diagnostics market analysis is also optimistic for more bacterial sepsis market growth and further dominates the market.

However, it also needs to be noted that after the pandemic of Covid-19, healthcare professionals and researchers are now more concerned about the emergence of any new virus that would be dangerous for mankind like Coronavirus. Therefore, this conundrum will surely bring sufficient opportunities for the viral sepsis diagnostic market.

Which End-user Segment Contributes the most in the Sepsis Diagnostic Market?

Hospitals are the major end users of the Sepsis diagnostics market by the tally of tests of patients coming to the hospital daily. Other than that, pathologies and reference laboratories also undertake a sufficient number of sepsis diagnostic tests on a daily basis and follow the hospital segment by marginal points.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Which Region Holds the Highest Growth Potential in the Sepsis Diagnostics Market?

The North America sepsis diagnostics market is projected to exceed a value of US$ 200 Mn by the year 2026.

Unavailability of highly skilled lab technicians in the developing regions of Asia Pacific regions, the growth of the Sepsis diagnostic market was not impressive earlier. But the increasing number of new product approvals and launches has provided new life to the market of this region.

The rising population in the Asia Pacific excluding Japan (APEJ) region and their improving living standards also boost the region's healthcare spending. This has, in turn, provided immense opportunity for the emerging market of septic diagnostic services in these regions.

Also, as the average year of the global population is growing, it will surely raise the demand for sepsis diagnostics devices for sepsis cure-all across the globe equally.

How Intense is the Competition in the Sepsis Diagnostics Market?

The Major Players in the global sepsis diagnostic market are Abbott, Becton, Dickinson, and Company, bioMérieux SA, Bruker Corporation, F. Hoffmann-LA Roche Ltd, Immunexpress Inc., Diasorin, Response Biomedical Corp., T2 Biosystems, Inc., and Thermo Fisher Scientific. 

Various sepsis diagnostic companies are investing in research and development for new methods and equipment to reduce the time taken by the cumbersome preexisting sepsis diagnostic process.

Because of the limited reach of sepsis diagnostic services except in North America, significant players in this market are getting into agreements for collaborations and partnerships for expanding their market outreach.

Major Developments in Sepsis Diagnostics Market:

  • Immunexpress launched a one-hour molecular diagnostic test for sepsis named rapid SeptiCyte in 2020. It is a fully-integrated test that delivers quick results based on the immune response.
  • Biofire Mycoplasma is another fully automated test that can deliver results within hours. This rapid and easy to use a molecular diagnostic test to detect mycoplasma in biotherapeutics products was introduced by a French biotechnology Company named BioMeriux SA in the year 2020.
  • To make its rapid sepsis diagnostic system more prevalent among patients in other regional markets, Cytovale Inc. has signed a partnership with the Biomedical Advanced Research and Development Authority (BARDA) in 2020. This system is particularly beneficial for patients with the chance of respiratory illness.

Key Segments

By Product:

  • Blood Culture Media
  • Assays & Reagents
  • Instruments, and Software

By Technology:

  • Blood Culture
  • Immunoassays
  • Molecular Diagnostics
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

By Method:

  • Automated Diagnostics
  • Conventional Diagnostics

By Pathogen:

  • Bacterial Sepsis
  • Fungal Sepsis
  • Viral Sepsis
  • Others

By Test Type:

  • Laboratory Tests
  • Point-of-Care Tests

By End User:

  • Hospitals and Specialty Clinics
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The sepsis diagnostics market is predicted to expand at a 9% CAGR by 2032.

The sepsis molecular diagnostics market was valued at $500 million in 2021.

The sepsis molecular diagnostics market is expected to hit US$1.3 Bn by 2032.

The adoption trend of sepsis diagnostics devices is anticipated to remain the highest in North America.

The sepsis diagnostics market is estimated to reach US$ 770 Mn by 2026.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Sepsis Diagnostics Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Componentulation and Product Development Trends

4. Market Background

    4.1. Sepsis Diagnostics Market By Country, US$ Mn

    4.2. Sepsis Diagnostics Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Sepsis Diagnostics Market Growth

        4.5.3. Sepsis Diagnostics Adoption Rate, by Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Sepsis Diagnostics Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Sepsis Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Sepsis Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) and Analysis By Product, 2015-2021

    8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Product, 2022-2032

        8.3.1. Blood Culture Media

        8.3.2. Assays & Reagents

        8.3.3. Instruments

        8.3.4. Software

    8.4. Market Attractiveness Analysis By Product

9. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Technology

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) and Analysis By Technology, 2015-2021

    9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Technology, 2022-2032

        9.3.1. Blood Culture

        9.3.2. Immunoassays

        9.3.3. Molecular Diagnostics

            9.3.3.1. PCR

            9.3.3.2. Peptide Nucleic Acid-Fluorescent In Situ Hybridization

            9.3.3.3. Microarrays

            9.3.3.4. DNA Sequencing

            9.3.3.5. Syndromic Panel-Based Testing

        9.3.4. Flow Cytometry

        9.3.5. Microfluidics

        9.3.6. Biomarkers

    9.4. Market Attractiveness Analysis By Technology

10. Global Sepsis Diagnostics Market  Analysis 2015-2021 and Forecast 2022-2032, By Method

        10.1.1. 10.1.Introduction / Key Findings

        10.1.2. 10.2.Historical Market Value (US$ Mn) and Analysis By Method, 2015-2021

        10.1.3. 10.3.Current and Future Market Value (US$ Mn) and Analysis and Forecast By Method, 2022-2032

            10.1.3.1. 10.3.1.  Automated Diagnostics

            10.1.3.2. 10.3.2.  Conventional Diagnostics

        10.1.4. 10.4.Market Attractiveness Analysis By Method

11. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Pathogen

        11.1.1. 11.1.Introduction / Key Findings

        11.1.2. 11.2.Historical Market Value (US$ Mn) and Analysis By Pathogen, 2015-2021

        11.1.3. 11.3.Current and Future Market Value (US$ Mn) and Analysis and Forecast By Pathogen, 2022-2032

            11.1.3.1. 11.3.1.      Bacterial Sepsis

            11.1.3.2. 11.3.2.      Fungal Sepsis

            11.1.3.3. 11.3.3.      Viral Sepsis

            11.1.3.4. 11.3.4.      Other Pathogen

        11.1.4. 11.4.Market Attractiveness Analysis By Pathogen

12. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Test Type

        12.1.1. 12.1.Introduction / Key Findings

        12.1.2. 12.2.Historical Market Value (US$ Mn) and Analysis By Test Type, 2015-2021

        12.1.3. 12.3.Current and Future Market Value (US$ Mn) and Analysis and Forecast By Test Type, 2022-2032

            12.1.3.1. 12.3.1.      Laboratory Tests

            12.1.3.2. 12.3.2.      Point-of-Care Tests

        12.1.4. 12.4.Market Attractiveness Analysis By Test Type

13. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End-User

    13.1. Introduction

    13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021

    13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        13.3.1. Hospitals and Specialty Clinics

        13.3.2. Pathology & Reference Laboratories

        13.3.3. Research Laboratories & Academic Institutes

    13.4. Market Attractiveness Analysis By Region

14. Global Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    14.1. Introduction

    14.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021

    14.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. Asia Pacific

        14.3.5. Middle East and Africa (MEA)

    14.4. Market Attractiveness Analysis By Region

15. North America Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

            15.3.1.1. 15.4.          Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1.      By Country

                15.3.1.1.1. 15.4.1.1. U.S.

                15.3.1.1.2. 15.4.1.2. Canada

            15.3.1.2. 15.4.2.      By Method

            15.3.1.3. 15.4.3.      By Product

            15.3.1.4. 15.4.4.      By Technology

            15.3.1.5. 15.4.5.      By Pathogen

            15.3.1.6. 15.4.6.      By Test Type

            15.3.1.7. 15.4.7.      By End-User

    15.4. Market Attractiveness Analysis

            15.4.1.1. 15.5.1.      By Country

            15.4.1.2. 15.5.2.      By Method

            15.4.1.3. 15.5.3.      By Product

            15.4.1.4. 15.5.4.      By Technology

            15.4.1.5. 15.5.5.      By Pathogen

            15.4.1.6. 15.5.6.      By Test Type

            15.4.1.7. 15.5.7.      By End-User 

16. Latin America Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. Brazil

            16.4.1.2. Mexico

            16.4.1.3. Rest of Latin America

        16.4.2. By Method

        16.4.3. By Product

        16.4.4. By Technology

        16.4.5. By Pathogen

        16.4.6. By Test Type

        16.4.7. By End-User

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Method

        16.5.3. By Product

        16.5.4. By Technology

        16.5.5. By Pathogen

        16.5.6. By Test Type

        16.5.7. By End-User

17. Europe Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        17.4.1. By Country

            17.4.1.1. Germany

            17.4.1.2. France

            17.4.1.3. U.K.

            17.4.1.4. Italy

            17.4.1.5. Benelux

            17.4.1.6. Russia

            17.4.1.7. Rest of Europe

        17.4.2. By Method

        17.4.3. By Product

        17.4.4. By Technology

        17.4.5. By Pathogen

        17.4.6. By Test Type

        17.4.7. By End-User

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Method

        17.5.3. By Product

        17.5.4. By Technology

        17.5.5. By Pathogen

        17.5.6. By Test Type

        17.5.7. By End-User 

18. Asia Pacific Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    18.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        18.4.1. By Country

            18.4.1.1. China

            18.4.1.2. Japan

            18.4.1.3. South Korea

            18.4.1.4. Rest of Asia Pacific

        18.4.2. By Method

        18.4.3. By Product

        18.4.4. By Technology

        18.4.5. By Pathogen

        18.4.6. By Test Type

        18.4.7. By End-User

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Method

        18.5.3. By Product

        18.5.4. By Technology

        18.5.5. By Pathogen

        18.5.6. By Test Type

        18.5.7. By End-User

19. Middle East and Africa Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    19.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        19.4.1. By Country

            19.4.1.1. GCC Countries

            19.4.1.2. South Africa

            19.4.1.3. Turkey

            19.4.1.4. Rest of Middle East and Africa

        19.4.2. By Method

        19.4.3. By Product

        19.4.4. By Technology

        19.4.5. By Pathogen

        19.4.6. By Test Type

        19.4.7. By End-User

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Method

        19.5.3. By Product

        19.5.4. By Technology

        19.5.5. By Pathogen

        19.5.6. By Test Type

        19.5.7. By End-User

20. Key Countries Sepsis Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. US Sepsis Diagnostics Market Analysis

        20.2.1. Value Proportion Analysis by Market Taxonomy

        20.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.2.2.1. By Method

            20.2.2.2. By Product

            20.2.2.3. By Technology

            20.2.2.4. By Pathogen

            20.2.2.5. By Test Type

            20.2.2.6. By End-User

    20.3. Canada Sepsis Diagnostics Market Analysis

        20.3.1. Value Proportion Analysis by Market Taxonomy

        20.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.3.2.1. By Method

            20.3.2.2. By Product

            20.3.2.3. By Technology

            20.3.2.4. By Pathogen

            20.3.2.5. By Test Type

            20.3.2.6. By End-User  

    20.4. Mexico Sepsis Diagnostics Market Analysis

        20.4.1. Value Proportion Analysis by Market Taxonomy

        20.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.4.2.1. By Method

            20.4.2.2. By Product

            20.4.2.3. By Technology

            20.4.2.4. By Pathogen

            20.4.2.5. By Test Type

            20.4.2.6. By End-User  

    20.5. Brazil Sepsis Diagnostics Market Analysis

        20.5.1. Value Proportion Analysis by Market Taxonomy

        20.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.5.2.1. By Method

            20.5.2.2. By Product

            20.5.2.3. By Technology

            20.5.2.4. By Pathogen

            20.5.2.5. By Test Type

            20.5.2.6. By End-User  

    20.6. Germany Sepsis Diagnostics Market Analysis

        20.6.1. Value Proportion Analysis by Market Taxonomy

        20.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.6.2.1. By Method

            20.6.2.2. By Product

            20.6.2.3. By Technology

            20.6.2.4. By Pathogen

            20.6.2.5. By Test Type

            20.6.2.6. By End-User  

    20.7. France Sepsis Diagnostics Market Analysis

        20.7.1. Value Proportion Analysis by Market Taxonomy

        20.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.7.2.1. By Method

            20.7.2.2. By Product

            20.7.2.3. By Technology

            20.7.2.4. By Pathogen

            20.7.2.5. By Test Type

            20.7.2.6. By End-User  

    20.8. Italy Sepsis Diagnostics Market Analysis

        20.8.1. Value Proportion Analysis by Market Taxonomy

        20.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.8.2.1. By Method

            20.8.2.2. By Product

            20.8.2.3. By Technology

            20.8.2.4. By Pathogen

            20.8.2.5. By Test Type

            20.8.2.6. By End-User 

    20.9. Russia Sepsis Diagnostics Market Analysis

        20.9.1. Value Proportion Analysis by Market Taxonomy

        20.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.9.2.1. By Method

            20.9.2.2. By Product

            20.9.2.3. By Technology

            20.9.2.4. By Pathogen

            20.9.2.5. By Test Type

            20.9.2.6. By End-User  

    20.10. UK Sepsis Diagnostics Market Analysis

        20.10.1. Value Proportion Analysis by Market Taxonomy

        20.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.10.2.1. By Method

            20.10.2.2. By Product

            20.10.2.3. By Technology

            20.10.2.4. By Pathogen

            20.10.2.5. By Test Type

            20.10.2.6. By End-User  

    20.11. Benelux Sepsis Diagnostics Market Analysis

        20.11.1. Value Proportion Analysis by Market Taxonomy

        20.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.11.2.1. By Method

            20.11.2.2. By Product

            20.11.2.3. By Technology

            20.11.2.4. By Pathogen

            20.11.2.5. By Test Type

            20.11.2.6. By End-User  

    20.12. China Sepsis Diagnostics Market Analysis

        20.12.1. Value Proportion Analysis by Market Taxonomy

        20.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.12.2.1. By Method

            20.12.2.2. By Product

            20.12.2.3. By Technology

            20.12.2.4. By Pathogen

            20.12.2.5. By Test Type

            20.12.2.6. By End-User  

    20.13. Japan Sepsis Diagnostics Market Analysis

        20.13.1. Value Proportion Analysis by Market Taxonomy

        20.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.13.2.1. By Method

            20.13.2.2. By Product

            20.13.2.3. By Technology

            20.13.2.4. By Pathogen

            20.13.2.5. By Test Type

            20.13.2.6. By End-User  

    20.14. South Korea Sepsis Diagnostics Market Analysis

        20.14.1. Value Proportion Analysis by Market Taxonomy

        20.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.14.2.1. By Method

            20.14.2.2. By Product

            20.14.2.3. By Technology

            20.14.2.4. By Pathogen

            20.14.2.5. By Test Type

            20.14.2.6. By End-User  

    20.15. GCC Countries Sepsis Diagnostics Market Analysis

        20.15.1. Value Proportion Analysis by Market Taxonomy

        20.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.15.2.1. By Method

            20.15.2.2. By Product

            20.15.2.3. By Technology

            20.15.2.4. By Pathogen

            20.15.2.5. By Test Type

            20.15.2.6. By End-User  

    20.16. South Africa Sepsis Diagnostics Market Analysis

        20.16.1. Value Proportion Analysis by Market Taxonomy

        20.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.16.2.1. By Method

            20.16.2.2. By Product

            20.16.2.3. By Technology

            20.16.2.4. By Pathogen

            20.16.2.5. By Test Type

            20.16.2.6. By End-User  

    20.17. Turkey Sepsis Diagnostics Market Analysis

        20.17.1. Value Proportion Analysis by Market Taxonomy

        20.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            20.17.2.1. By Method

            20.17.2.2. By Product

            20.17.2.3. By Technology

            20.17.2.4. By Pathogen

            20.17.2.5. By Test Type

            20.17.2.6. By End-User  

        20.17.3. Competition Landscape and Player Concentration in the Country

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. By Regional footprint of Players

        21.4.2. Product footprint by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. BIOMÉRIEUX

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Sales Footprint

            22.3.1.4. Strategy Overview

        22.3.2. BECTON, DICKINSON, AND COMPANY

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Sales Footprint

            22.3.2.4. Strategy Overview

        22.3.3. DANAHER CORPORATION

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Sales Footprint

            22.3.3.4. Strategy Overview

        22.3.4. T2 BIOSYSTEMS

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Sales Footprint

            22.3.4.4. Strategy Overview

        22.3.5. LUMINEX

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Sales Footprint

            22.3.5.4. Strategy Overview

        22.3.6. F. HOFFMANN-LA ROCHE AG

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Sales Footprint

            22.3.6.4. Strategy Overview

        22.3.7. THERMO FISHER SCIENTIFIC

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Sales Footprint

            22.3.7.4. Strategy Overview

        22.3.8. BRUKER CORPORATION

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Sales Footprint

            22.3.8.4. Strategy Overview

        22.3.9. ABBOTT LABORATORIES

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Sales Footprint

            22.3.9.4. Strategy Overview

        22.3.10. QUIDEL CORPORATION

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Sales Footprint

            22.3.10.4. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021

Table 2: Global Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032

Table 3: Global Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021

Table 4: Global Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032

Table 5: Global Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021

Table 6: Global Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032

Table 7: Global Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 8: Global Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 9: Global Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021

Table 10: Global Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032

Table 11: Global Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 12: Global Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 13: Global Sepsis Diagnostics Market, By Region, 2015 – 2021

Table 14: Global Sepsis Diagnostics Market, By Region, 2022 – 2032

Table 15: North America Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021

Table 16: North America Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032

Table 17: North America Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021

Table 18: North America Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032

Table 19: North America Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021

Table 20: North America Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032

Table 21: North America Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 22: North America Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 23: North America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021

Table 24: North America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032

Table 25: North America Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 26: North America Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 27: North America Sepsis Diagnostics Market, By Country, 2015 – 2021

Table 28: North America Sepsis Diagnostics Market, By Country, 2022 – 2032

Table 29: Latin America Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021

Table 30: Latin America Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032

Table 31: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021

Table 32: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032

Table 33: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021

Table 34: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032

Table 35: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 36: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 37: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021

Table 38: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032

Table 39: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 40: Latin America Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 41: Latin America Sepsis Diagnostics Market, By Country, 2015 – 2021

Table 42: Latin America Sepsis Diagnostics Market, By Country, 2022 – 2032

Table 43: Europe Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021

Table 44: Europe Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032

Table 45: Europe Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021

Table 46: Europe Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032

Table 47: Europe Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021

Table 48: Europe Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032

Table 49: Europe Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 50: Europe Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 51: Europe Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021

Table 52: Europe Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032

Table 53: Europe Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 54: Europe Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 55: Europe Sepsis Diagnostics Market, By Country, 2015 – 2021

Table 56: Europe Sepsis Diagnostics Market, By Country, 2022 – 2032

Table 57: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021

Table 58: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032

Table 59: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021

Table 60: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032

Table 61: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021

Table 62: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032

Table 63: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 64: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 65: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021

Table 66: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032

Table 67: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 68: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 69: Asia Pacific Sepsis Diagnostics Market, By Country, 2015 – 2021

Table 70: Asia Pacific Sepsis Diagnostics Market, By Country, 2022 – 2032

Table 71: MEA Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2015 – 2021

Table 72: MEA Sepsis Diagnostics Market Value (US$ Mn),By End-User, 2022 – 2032

Table 73: MEA Sepsis Diagnostics Market Value (US$ Mn), By Product, 2015 – 2021

Table 74: MEA Sepsis Diagnostics Market Value (US$ Mn), By Product, 2022 – 2032

Table 75: MEA Sepsis Diagnostics Market Value (US$ Mn), By Method, 2015 – 2021

Table 76: MEA Sepsis Diagnostics Market Value (US$ Mn), By Method, 2022 – 2032

Table 77: MEA Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 78: MEA Sepsis Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 79: MEA Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2015 – 2021

Table 80: MEA Sepsis Diagnostics Market Value (US$ Mn), By Pathogen, 2022 – 2032

Table 81: MEA Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 82: MEA Sepsis Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 83: MEA Sepsis Diagnostics Market, By Country, 2015 – 2021

Table 84: MEA Sepsis Diagnostics Market, By Country, 2022 – 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Sepsis Diagnostics Market Share,By End-User, 2022 & 2032

Figure 4: Global Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032

Figure 5: Global Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032

Figure 6: Global Sepsis Diagnostics Market Share, By Product, 2022 & 2032

Figure 7: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 8: Global Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 9: Global Sepsis Diagnostics Market Share, By Technology, 2022 & 2032

Figure 10: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 11: Global Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 12: Global Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 13: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 14: Global Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 15: Global Sepsis Diagnostics Market Share, By Method, 2022 & 2032

Figure 16: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 17: Global Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032

Figure 18: Global Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032

Figure 19: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032

Figure 20: Global Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032

Figure 21: Global Sepsis Diagnostics Market Share, By Region, 2022 & 2032

Figure 22: Global Sepsis Diagnostics Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 23: Global Sepsis Diagnostics Market Attractiveness Index, By Region – 2022-2032

Figure 24: North America Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 25: North America Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 26: North America Sepsis Diagnostics Market Share,By End-User, 2022 & 2032

Figure 27: North America Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032

Figure 28: North America Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032

Figure 29: North America Sepsis Diagnostics Market Share, By Product, 2022 & 2032

Figure 30: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 31: North America Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 32: North America Sepsis Diagnostics Market Share, By Technology, 2022 & 2032

Figure 33: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 34: North America Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 35: North America Sepsis Diagnostics Market Share, By Method, 2022 & 2032

Figure 36: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 37: North America Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032

Figure 38: North America Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032

Figure 39: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032

Figure 40: North America Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032

Figure 41: North America Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 42: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 43: North America Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 44: North America Sepsis Diagnostics Market Share, By Country, 2022 & 2032

Figure 45: North America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 46: North America Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 47: Latin America Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 48: Latin America Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 49: Latin America Sepsis Diagnostics Market Share,By End-User, 2022 & 2032

Figure 50: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032

Figure 51: Latin America Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032

Figure 52: Latin America Sepsis Diagnostics Market Share, By Product, 2022 & 2032

Figure 53: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 54: Latin America Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 55: Latin America Sepsis Diagnostics Market Share, By Technology, 2022 & 2032

Figure 56: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 57: Latin America Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 58: Latin America Sepsis Diagnostics Market Share, By Method, 2022 & 2032

Figure 59: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 60: Latin America Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032

Figure 61: Latin America Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032

Figure 62: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032

Figure 63: Latin America Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032

Figure 64: Latin America Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 65: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 66: Latin America Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 67: Latin America Sepsis Diagnostics Market Share, By Country, 2022 & 2032

Figure 68: Latin America Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 69: Latin America Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 70: Europe Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 71: Europe Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 72: Europe Sepsis Diagnostics Market Share,By End-User, 2022 & 2032

Figure 73: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032

Figure 74: Europe Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032

Figure 75: Europe Sepsis Diagnostics Market Share, By Product, 2022 & 2032

Figure 76: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 77: Europe Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 78: Europe Sepsis Diagnostics Market Share, By Technology, 2022 & 2032

Figure 79: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 80: Europe Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 81: Europe Sepsis Diagnostics Market Share, By Method, 2022 & 2032

Figure 82: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 83: Europe Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032

Figure 84: Europe Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032

Figure 85: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032

Figure 86: Europe Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032

Figure 87: Europe Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 88: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 89: Europe Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 90: Europe Sepsis Diagnostics Market Share, By Country, 2022 & 2032

Figure 91: Europe Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 92: Europe Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 93: Asia Pacific Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 94: Asia Pacific Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 95: Asia Pacific Sepsis Diagnostics Market Share,By End-User, 2022 & 2032

Figure 96: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032

Figure 97: Asia Pacific Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032

Figure 98: Asia Pacific Sepsis Diagnostics Market Share, By Product, 2022 & 2032

Figure 99: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 100: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 101: Asia Pacific Sepsis Diagnostics Market Share, By Technology, 2022 & 2032

Figure 102: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 103: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 104: Asia Pacific Sepsis Diagnostics Market Share, By Method, 2022 & 2032

Figure 105: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 106: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032

Figure 107: Asia Pacific Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032

Figure 108: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032

Figure 109: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032

Figure 110: Asia Pacific Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 111: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 112: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 113: Asia Pacific Sepsis Diagnostics Market Share, By Country, 2022 & 2032

Figure 114: Asia Pacific Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 115: Asia Pacific Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 116: MEA Sepsis Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 117: MEA Sepsis Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 118: MEA Sepsis Diagnostics Market Share,By End-User, 2022 & 2032

Figure 119: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections,By End-User – 2022-2032

Figure 120: MEA Sepsis Diagnostics Market Attractiveness Index,By End-User – 2022-2032

Figure 121: MEA Sepsis Diagnostics Market Share, By Product, 2022 & 2032

Figure 122: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 123: MEA Sepsis Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 124: MEA Sepsis Diagnostics Market Share, By Technology, 2022 & 2032

Figure 125: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 126: MEA Sepsis Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 127: MEA Sepsis Diagnostics Market Share, By Method, 2022 & 2032

Figure 128: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Method – 2022-2032

Figure 129: MEA Sepsis Diagnostics Market Attractiveness Index, By Method – 2022-2032

Figure 130: MEA Sepsis Diagnostics Market Share, By Pathogen, 2022 & 2032

Figure 131: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Pathogen – 2022-2032

Figure 132: MEA Sepsis Diagnostics Market Attractiveness Index, By Pathogen – 2022-2032

Figure 133: MEA Sepsis Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 134: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 135: MEA Sepsis Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 136: MEA Sepsis Diagnostics Market Share, By Country, 2022 & 2032

Figure 137: MEA Sepsis Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 138: MEA Sepsis Diagnostics Market Attractiveness Index, By Country – 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Sepsis Diagnostics Market